OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting
OKYO Pharma Announces Acceptance of Urcosimod Phase 2 Study Results for Presentation at Prestigious ASCRS Annual Meeting
OKYO Pharma Announces New Data Showing Favorable Corneal Nerve Outcomes in Phase 2 Study for Neuropathic Corneal Pain
OKYO Pharma Announces Registration Pathway with 100 Patient Multi-Center Clinical Trial of Urcosimod in Neuropathic Corneal Pain
Tartisan Nickel Corp. Appoints Jack Jacobs, Congressional Medal of Honour Recipient, Retired Army Colonel and Distinguished Business Executive to Board of Advisors
Rio Silver Highlights Underexplored Silver-Gold Potential at Maria Norte Within a Proven Peruvian Mining District
Standard Uranium Set to Drill the Corvo Project Including the High-Grade Manhattan Uranium Showing with 8.10% U3O8 Surface Sample
CoTec Notes Portfolio Company HyProMag USA Advances U.S. Hub-And-Spoke Strategy With Arrival of Inserma HDD Pre-Processing Machines at South Carolina and Nevada Sites
